Category - Executive Moves

Executive Moves

BriaCell Therapeutics names Richard Berman to board

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) appointed Richard Berman to its board of directors. Mr. Berman has more than 35 years of experience in venture capital; senior management; and mergers and acquisitions. He...

August 13, 2019

Executive Moves

Kane Biotech strengthens animal health and quality assurance team

Kane Biotech (TSXV:KNE) added to its management team, hiring Lori Christofalos as the director of quality and compliance; Shabnam Bashiri as manager of quality control; and Michel Stebenne as VP of animal health. Ms...

August 12, 2019

Executive Moves

Hepion Pharma names renowned liver expert, Dr. Stephen Harrison, to its SAB

Dr. Stephen Harrison, a leading authority on liver diseases, has joined the scientific advisory board (SAB) of Hepion Pharmaceuticals (NASDAQ:HEPA). Dr. Harrison is a visiting professor of hepatology at the Radcliffe...

August 7, 2019

Executive Moves

Soricimed taps industry veteran, Robert Bruce, as CEO

Closely-held Soricimed Biopharma appointed Robert Bruce as CEO, effective immediately, succeeding Paul Gunn, who continues as president. “Soricimed is taking an important step forward at this time and I am excited to...

July 17, 2019

Executive Moves

PharmaCyte appoints cellular expert, David Judd, to medical and SAB

PharmaCyte Biotech (OTCQB: PMCB) appointed David Judd to its medical and scientific advisory board. Mr. Judd has had over 30 years of experience in the research and development of cell culture materials and methods for...

July 15, 2019

Executive Moves

Rahul Sarugaser joins Raymond James’ life sciences research team

Rahul Sarugaser has joined Raymond James’ Canadian equity research team as managing director, equity analyst, healthcare, biotechnology & cannabis. Most recently, Mr. Sarugaser was an equities research analyst at...

July 12, 2019

Executive Moves

John Baumgartner named Lake Street’s head of capital markets

Lake Street Capital Markets has named John Baumgartner as its head of capital markets, responsible for overseeing marketing, pricing, and distribution of its capital raising activities. Mr. Baumgartner began his career...

July 12, 2019

Executive Moves

IDEAYA Biosciences makes three appointments to management team

IDEAYA Biosciences (NASDAQ:IDYA) promoted Paul Stone to CFO, Andres Briseno to VP finance, and Mick O’Quigley to VP development operations. Continuing his role as IDEAYA’s principal financial and accounting...

July 9, 2019

Executive Moves

ORIC Pharma names Lori Friedman as CSO

Closely-held ORIC Pharmaceuticals appointed Lori Friedman as CSO, responsible for leading ORIC’s research and preclinical development efforts.

July 9, 2019

Executive Moves

Zenabis’ expansion welcomed by Stellarton residents

Zenabis Global’s (TSX:ZENA) expansion in Stellarton, Nova Scotia, is good news for local residents, as the company is looking to fill several positions at that particular facility this summer.

July 4, 2019

Category - Executive Moves

BriaCell Therapeutics names Richard Berman to board

Kane Biotech strengthens animal health and quality assurance team

Hepion Pharma names renowned liver expert, Dr. Stephen Harrison, to its SAB

Soricimed taps industry veteran, Robert Bruce, as CEO

PharmaCyte appoints cellular expert, David Judd, to medical and SAB

Rahul Sarugaser joins Raymond James’ life sciences research team

John Baumgartner named Lake Street’s head of capital markets

IDEAYA Biosciences makes three appointments to management team

ORIC Pharma names Lori Friedman as CSO

Zenabis’ expansion welcomed by Stellarton residents

Follow Us

Subscribe

General

More

Subscribe